Literature DB >> 7782801

Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study.

J Ma1, A R Folsom, S L Melnick, J H Eckfeldt, A R Sharrett, A A Nabulsi, R G Hutchinson, P A Metcalf.   

Abstract

The objective of this study was to examine the relationships of serum and dietary magnesium (Mg) with prevalent cardiovascular disease (CVD), hypertension, diabetes mellitus, fasting insulin, and average carotid intimal-medial wall thickness measured by B-mode ultrasound. A cross-sectional design was used. The setting was the Atherosclerosis Risk in Communities (ARIC) Study in four US communities. A total of 15,248 participants took part, male and female, black and white, aged 45-64 years. Fasting serum Mg, lipids, fasting glucose and insulin were measured; as was usual dietary intake by food frequency questionnaire and carotid intima-media thickness by standardized B-mode ultrasound methods. The results showed that serum Mg levels and dietary Mg intake were both lower in blacks than whites. Mean serum Mg levels were significantly lower in participants with prevalent CVD, hypertension, and diabetes than in those free of these diseases. In participants without CVD, serum Mg levels were also inversely associated with fasting serum insulin, glucose, systolic blood pressure and smoking. Dietary Mg intake was inversely associated with fasting serum insulin, plasma high density lipoprotein-cholesterol, systolic and diastolic blood pressure. Adjusted for age, race, body mass index, smoking, hypertension, Low density lipoprotein-cholesterol, and field center, mean carotid wall thickness increased in women by 0.0118 mm (p = 0.006) in diuretic users and 0.0048 mm (p = 0.017) in nonusers for each 0.1 mmol/l decrease in serum Mg level; the multivariate association in men was not significant. In conclusion, low serum and dietary Mg may be related to the etiologies of CVD, hypertension, diabetes, and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782801     DOI: 10.1016/0895-4356(94)00200-a

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  84 in total

1.  Inhibitory effect of deep-sea water on differentiation of 3T3-L1 adipocytes.

Authors:  Hee Sun Hwang; Seon Hwa Kim; Yung Geun Yoo; Yong Shik Chu; Yun Hee Shon; Kyung Soo Nam; Jong Won Yun
Journal:  Mar Biotechnol (NY)       Date:  2008-07-25       Impact factor: 3.619

2.  Modulation of lipid metabolism by deep-sea water in cultured human liver (HepG2) cells.

Authors:  Shan He; Jiejie Hao; Weibing Peng; Peiju Qiu; Chunxia Li; Huashi Guan
Journal:  Mar Biotechnol (NY)       Date:  2013-09-24       Impact factor: 3.619

3.  Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.

Authors:  Nilank C Shah; Gatha J Shah; Zhiqiang Li; Xian-Cheng Jiang; Bella T Altura; Burton M Altura
Journal:  Int J Clin Exp Med       Date:  2014-03-15

4.  Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies.

Authors:  Adela Hruby; Julius S Ngwa; Frida Renström; Mary K Wojczynski; Andrea Ganna; Göran Hallmans; Denise K Houston; Paul F Jacques; Stavroula Kanoni; Terho Lehtimäki; Rozenn N Lemaitre; Ani Manichaikul; Kari E North; Ioanna Ntalla; Emily Sonestedt; Toshiko Tanaka; Frank J A van Rooij; Stefania Bandinelli; Luc Djoussé; Efi Grigoriou; Ingegerd Johansson; Kurt K Lohman; James S Pankow; Olli T Raitakari; Ulf Riserus; Mary Yannakoulia; M Carola Zillikens; Neelam Hassanali; Yongmei Liu; Dariush Mozaffarian; Constantina Papoutsakis; Ann-Christine Syvänen; André G Uitterlinden; Jorma Viikari; Christopher J Groves; Albert Hofman; Lars Lind; Mark I McCarthy; Vera Mikkilä; Kenneth Mukamal; Oscar H Franco; Ingrid B Borecki; L Adrienne Cupples; George V Dedoussis; Luigi Ferrucci; Frank B Hu; Erik Ingelsson; Mika Kähönen; W H Linda Kao; Stephen B Kritchevsky; Marju Orho-Melander; Inga Prokopenko; Jerome I Rotter; David S Siscovick; Jacqueline C M Witteman; Paul W Franks; James B Meigs; Nicola M McKeown; Jennifer A Nettleton
Journal:  J Nutr       Date:  2013-01-23       Impact factor: 4.798

5.  Serum levels of magnesium and their relationship with CRP in patients with OSA.

Authors:  H Karamanli; D Kizilirmak; R Akgedik; M Bilgi
Journal:  Sleep Breath       Date:  2016-09-06       Impact factor: 2.816

6.  Dietary magnesium intake is related to metabolic syndrome in older Americans.

Authors:  Nicola M McKeown; Paul F Jacques; Xinli L Zhang; Wenyen Juan; Nadine R Sahyoun
Journal:  Eur J Nutr       Date:  2008-06-16       Impact factor: 5.614

7.  Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis.

Authors:  Faruk Turgut; Mehmet Kanbay; Melike Rusen Metin; Ebru Uz; Ali Akcay; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2008-06-21       Impact factor: 2.370

8.  Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study.

Authors:  Adela Hruby; Christopher J O'Donnell; Paul F Jacques; James B Meigs; Udo Hoffmann; Nicola M McKeown
Journal:  JACC Cardiovasc Imaging       Date:  2013-11-27

Review 9.  Magnesium in disease prevention and overall health.

Authors:  Stella Lucia Volpe
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

Review 10.  Magnesium and type 2 diabetes.

Authors:  Mario Barbagallo; Ligia J Dominguez
Journal:  World J Diabetes       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.